Endonasal resection of orbital cavernous venous malformations with septal preservation

2021 ◽  
pp. 103021
Author(s):  
Wilson P. Lao ◽  
Hector A. Perez ◽  
Kristelle J. Lagabon ◽  
Kenneth De Los Reyes ◽  
Steve C. Lee
Keyword(s):  
Venous Malformations

Percutaneous sclerotherapy for spongiform venous malformations – analysis of patient-evaluated outcome and satisfaction

VASA ◽  
2017 ◽  
Vol 46 (6) ◽  
pp. 477-483
Author(s):  
Robert Karl Clemens ◽  
Frederic Baumann ◽  
Marc Husmann ◽  
Thomas Oleg Meier ◽  
Christoph Thalhammer ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Medical Records ◽  
Venous Malformation ◽  
Primary Treatment ◽  
Venous Malformations ◽  
Treated Area ◽  
Item Questionnaire ◽  
Percutaneous Sclerotherapy ◽  
Multiple Treatments ◽  
Pain Improvement

Abstract. Background: Congenital venous malformations are frequently treated with sclerotherapy. Primary treatment goal is to control the often size-related symptoms. Functional impairment and aesthetical aspects as well as satisfaction have rarely been evaluated. Patients and methods: Medical records of patients who underwent sclerotherapy of spongiform venous malformations were reviewed and included in this retrospective study. The outcome of sclerotherapy as self-reported by patients was assessed in a 21 item questionnaire. Results: Questionnaires were sent to 166 patients with a total of 327 procedures. Seventy-seven patients (48 %) with a total of 159 procedures (50 %) responded to the survey. Fifty-seven percent of patients were male. The age ranged from 1 to 38.1 years with a median age of 16.4 years. The lower extremities were the most common treated area. Limitations caused by the venous malformation improved in the majority of patients (e.g. pain improvement 87 %, improvement of swelling 83 %) but also worsening of symptoms occurred in a minority of cases. Seventy-seven per cent would undergo sclerotherapy again. Conclusions: Sclerotherapy for treatment of venous malformations results in significant reduction of symptoms. Multiple treatments are often needed, but patients are willing to undergo them.

scholarly journals Novel Compliant Stent with Specific Design for Truncular Venous Malformations: Results of a Porcine Model Study

2019 ◽  
Vol 58 (6) ◽  
pp. e514-e515
Author(s):  
Pierfrancesco Veroux ◽  
Alessia Giaquinta ◽  
Giulia Bernardini ◽  
Carla Virgilio ◽  
Massimiliano Veroux
Keyword(s):  
Porcine Model ◽  
Venous Malformations ◽  
Specific Design ◽  
Model Study

scholarly journals Subconjunctival Hemorrhage in a Child with the Blue Rubber Bleb Nevus Syndrome on Treatment with Oral Propranolol

2021 ◽  
pp. 451-456
Author(s):  
Karen De Loecker ◽  
Veerle Labarque ◽  
Hilde Seynaeve ◽  
Ingele Casteels
Keyword(s):  
Central Nervous System ◽  
Topical Treatment ◽  
Vascular Lesions ◽  
Venous Malformations ◽  
Timolol Maleate ◽  
Cutaneous Lesions ◽  
Subconjunctival Hemorrhage ◽  
First Case ◽  
Β Blocker ◽  
Oral Propranolol

Blue rubber bleb nevus syndrome (BRBNS) is a rare syndrome characterized by venous malformations of mostly skin and gastrointestinal tract. Patients present with multiple venous malformations in various organs including liver, spleen, heart, eye, and central nervous system. Few ophthalmological cases have been published in literature and at present, there are no clear guidelines on the treatment of eye hemorrhages associated with the BRBNS. We report a 3-year-old boy with the BRBNS who developed a spontaneous progressive enlarging subconjunctival hemorrhage in the left eye despite being treated with oral propranolol. The subconjunctival hemorrhage was caused by an underlying conjunctival vascular malformation. With topical treatment with timolol maleate 0.5% once a day in the affected eye, the lesion regressed completely after 4 months. This child represents the first case of the BRBNS associated with a subconjunctival progressive bleeding necessitating topical treatment despite oral propranolol effectively controlling the cutaneous lesions. We recommend ophthalmic screening of patients with BRBNS in early childhood. For patients with BRBNS-related subconjunctival vascular lesions with subsequent hemorrhage, treatment with a topical β-blocker may be an efficient and harmless treatment option.

Cutaneous venous malformations as a clue for possible gastrointestinal tract involvement: Diagnosis and treatment of six cases

2021 ◽  
Author(s):  
Andrea Diociaiuti ◽  
Roberta Rotunno ◽  
Tamara Caldaro ◽  
Sabrina Rossi ◽  
Claudia Carnevale ◽  
...  
Keyword(s):  
Gastrointestinal Tract ◽  
Diagnosis And Treatment ◽  
Venous Malformations ◽  
Tract Involvement

Radio-opaque ethylcellulose-ethanol is a safe and efficient sclerosing agent for venous malformations

2011 ◽  
Vol 21 (12) ◽  
pp. 2647-2656 ◽  
Author(s):  
Anne Dompmartin ◽  
Xavier Blaizot ◽  
Jacques Théron ◽  
Frank Hammer ◽  
Yannick Chene ◽  
...  
Keyword(s):  
Venous Malformations ◽  
Sclerosing Agent

Clinical value of classification of venous malformations with contrast-enhanced MR Angiography

2016 ◽  
Vol 32 (9) ◽  
pp. 628-633 ◽  
Author(s):  
Ahmed Abdel Khalek Abdel Razek ◽  
Germeen Ashmalla Albair ◽  
Sieza Samir
Keyword(s):  
Mr Angiography ◽  
Treatment Plan ◽  
Venous Malformation ◽  
Observer Agreement ◽  
Type I ◽  
Venous Malformations ◽  
Single Measure ◽  
Intra Class Correlation ◽  
Contrast Enhanced

Aim To classify venous malformations based on contrast-enhanced MR angiography that may serve as a basis for treatment plan. Patients and methods A retrospective analysis was performed in 58 patients with venous malformations who underwent contrast-enhanced MR angiography. Venous malformations were classified according to their venous drainage into: type I, isolated malformation without peripheral drainage; type II, malformation that drains into normal veins; type III, malformation that drains into dilated veins; and type IV, malformation that represents dysplastic venous ectasia. Image analysis was done by two reviewers. Intra and inter-observer agreement of both reviewers and intra-class correlation was done. Results The intra-observer agreement of contrast-enhanced MR angiography classification of venous malformations was excellent for the first reviewer ( k = 0.83, 95% CI = 0.724–0.951, P = 0.001) and substantial for the second reviewer ( K = 0.79, 95% CI = 0.656-0.931, P = 0.001). The inter-observer agreement of contrast-enhanced MR angiography classification of venous malformations was excellent for both reviewers at the first time ( K = 0.96, 95% CI = 0.933–1.000, P = 0.001) and second time ( k = 0.81, 95% CI = 0.678–0.942, P = 0.001). There was high intra-class correlation of both reviewers for single measure ( ICC = 0.85, 95% CI = 0.776–0.918, P = 0.001) and for average measures ( ICC = 0.96, 95% CI = 0.933–0.978, P = 0.001). Conclusion Contrast-enhanced MR angiography classification of venous malformations may be a useful, simple and reliable tool to accurately classify venous malformation and this topographic classification helps for better management strategy.

Sign in / Sign up

Export Citation Format

Share Document